mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |